GLP-3 RT
GLP-3 RT is a synthetic 39-amino acid peptide and long-acting triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. Preclinical research explores its potent effects on weight loss, energy expenditure, and metabolic regulation.
Key Research Areas
- • Studied for concurrent agonism at GLP-1, GIP, and glucagon receptors for synergistic metabolic effects.
- • Investigated for substantial weight reduction through increased energy expenditure and reduced caloric intake.
- • Explored for improvements in glycemic control and lipid metabolism in obesity and type 2 diabetes research models.
Product Specifications
| Product |
GLP-3 RT |
| CAS Number |
2381089-83-2 |
| Molecular Formula |
C221H342N46O68 |
| Molar Mass |
4731.33 g/mol |
| Sequence |
Modified lipidated 39-amino acid peptide (triple agonist analog) |
| Synonyms |
GLP-3 RT; Reta LY3437943; triple agonist peptide |
| Purity |
≥99% (HPLC) |
| Form |
Lyophilized powder |
| Storage |
−20°C (−4°F) long-term; 2–8°C (36–46°F) reconstituted |
| Solubility |
Bacteriostatic water for laboratory use |
All products offered by Premier Research are intended for laboratory research use only. These materials are not for human or veterinary consumption, medical use, diagnostic procedures, or therapeutic applications. Statements on this website are for informational and educational purposes only and have not been evaluated by the U.S. Food and Drug Administration (FDA). By accessing this site, you confirm that you are a qualified researcher or institution representative and agree to use all materials in accordance with applicable laws, regulations, and safety guidelines.
